Research suggests that feverfew may offer some benefit for migraine relief, though the evidence base remains limited and conclusions should be drawn cautiously. A small randomized controlled trial found that a sublingual feverfew and ginger combination taken during the early, mild-pain phase of a migraine resulted in higher rates of pain freedom and pain reduction at two hours compared to placebo, suggesting potential utility as an early intervention. However, a 2016 review of clinical guidelines from major neurology organizations found that recommendations regarding feverfew for migraine prevention are inconsistent and sometimes contradictory across governing bodies, reflecting the broader uncertainty in the field. Overall, the existing research is preliminary in scope, and the two studies available here — one supportive RCT and one mixed review — do not yet constitute a robust or unified body of evidence from which firm conclusions can be drawn.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| A double-blind placebo-controlled pilot study of sublingual feverfew and ging... | RCT | 2011 | Supports | 72 |
| Nutraceuticals in Migraine: A Summary of Existing Guidelines for Use. | Review | 2016 | Mixed | 67 |